Winner Profile
Bangliang Li


CEO, Huadong Medicine

Industry: Health Care Distributors

Company size: X-Large
Published: 2017-12-08

Is Huadong Medicine a good stock investment?

Obermatt Stock Research Huadong Medicine

 

Based on the annual Obermatt CEO of the Year analysis, Bangliang Li (Huadong Medicine) earned the following Obermatt pins for the management performance.

Obermatt accolades Bangliang Li

Bangliang Li was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.

Performance Overview Bangliang Li

In summary, Bangliang Li obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):


CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 54 in Combined Performance indicates that Bangliang Li was better than 54% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for one participation in Obermatt CEO competitions. Bangliang Li’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.